Instructor, Obstetrics and Gynecology, University of California, Irvine College of Medicine
Obstetrics & Gynecology
Dr. Ramez N. Eskander, MD
|
|
Give Review
Ramez Eskander practices Obstetrics & Gynecology. He studied medicine at University of California San Diego School of Medicine. University of California San Diego School of Medicine is ranked 17 in research and 19 in primary care medicine He has 1 awards "Fellow (FACOG)". Ramez Eskander is a published doctor. He has 32 publications published. The most current publication "Early Initiation of Chemotherapy following Complete Resection of Advanced Ovarian Cancer Associated with Improved Survival: An NRG Oncology/Gynecologic Oncology Group ..." He accepts Medicare.
Publications
- Early Initiation of Chemotherapy following Complete Resection of Advanced Ovarian Cancer Associated with Improved Survival: An NRG Oncology/Gynecologic Oncology Group ...
- Development of bevacizumab in advanced Cervical cancer: pharmacodynamic modeling, survival impact and toxicology.
- Immunotherapy: an evolving paradigm in the treatment of advanced Cervical cancer.
- Targeting angiogenesis in advanced Cervical cancer.
- Evaluation of 30-Day Hospital Readmission After Surgery for Advanced-Stage Ovarian Cancer in a Medicare Population.
- Exploiting the therapeutic potential of the PI3K-AKT-mTOR pathway in enriched populations of gynecologic malignancies.
- Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Recurrent Ovarian Carcinoma: Analysis of 30-Day Morbidity and Mortality.
- Chemotherapy in the treatment of metastatic, persistent, and recurrent Cervical cancer.
- PARP inhibition and synthetic lethality in ovarian Cancer.
- Beyond angiogenesis blockade: targeted therapy for advanced Cervical cancer.
- Use of stereotactic radiosurgery in the treatment of gynecologic malignancies: A review.
- Assessment of palliative care training in gynecologic oncology: a gynecologic oncology fellow research network study.
- New paradigms in the surgical and adjuvant treatment of ovarian Cancer.
- Intraperitoneal Chemotherapy from Armstrong to HIPEC: Challenges and Promise.
- Incorporation of anti-angiogenesis therapy in the management of advanced ovarian Carcinoma-Mechanistics, review of phase III randomized clinical trials, and regulatory...
- American Society of Clinical Oncology 2013: Summary of Scientific Advancements in Gynecologic Cancer.
- Inhibition of enhancer of zeste homolog 2 (EZH2) expression is associated with decreased tumor cell proliferation, migration, and invasion in endometrial Cancer cell l...
- Dkk-3, a secreted wnt antagonist, suppresses tumorigenic potential and pulmonary metastasis in osteosarcoma.
- Outside Slide Review in Gynecologic Oncology: Impact on Patient Care and Treatment.
- Emerging treatment options for management of malignant ascites in patients with ovarian Cancer.
- Expression of the Wnt antagonist Dickkopf-3 is associated with prognostic clinicopathologic characteristics and impairs proliferation and invasion in endometrial Cancer.
- Flavokawain B, a novel, naturally occurring chalcone, exhibits robust apoptotic effects and induces G2/M arrest of a Uterine leiomyosarcoma cell line.
- Flavokawain B, a kava chalcone, induces apoptosis in synovial sarcoma cell lines.
- Chronic myelocytic leukemia in pregnancy: A case report describing successful treatment using multimodal therapy.
- Fertility preserving options in patients with gynecologic malignancies.
- Comparison of computed tomography and magnetic resonance imaging in Cervical cancer brachytherapy target and normal tissue contouring.
- Epithelial cell-adhesion molecule-directed trifunctional antibody immunotherapy for symptom management of advanced ovarian Cancer.
- Effect of predelivery diagnosis in 99 consecutive cases of placenta accreta.
- Accuracy of ultrasonography and magnetic resonance imaging in the diagnosis of placenta accreta.
- Bevacizumab in the treatment of ovarian Cancer.
- A retrospective review of the effect of surgeon specialty on the management of 190 benign and malignant pediatric and adolescent adnexal masses.
Schools
University of California At San Diego
Procedures Preformed
- Destruction or Excision of Vaginal Lesions
- EndoCervical Curettage
- Excision, Shaving, or Destruction of Skin and Subcutaneous Tissue (incl. Mohs Micrographic Surgery), Tissue Transfer
- Hysterectomy - Laparoscopic
- View All
Conditions Treated
- Carcinoma in Situ
- Cervical Cancer
- Hyperlipidemia
- Hypertension
- View All
Doctors Specialties
- Obstetrics
- Gynecology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Power Select HMO
- Blue Card PPO
- CaliforniaCare HMO
- Advantage Preferred DirectAccess Plus PPO
- Blue Cross Blue Shield of California PPO
- Pathway X Direct Access PPO
- Pathway X Guided Access HMO
- Pathway X Tiered Direct Access
- Priority Select HMO
- Select Plus HMO
- Enhanced Exclusive for Small Business HMO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- First Health (Coventry Health Care) PPO
- Medicare MCR
- Molina Healthcare
- MultiPlan PPO
- PHCS Network PPO
- Optima Health
- Heritage Signature
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- PacifiCare HMO
- United Healthcare
Awards
- Fellow (FACOG)
Education
-
University of California Irvine College of Medicine -
University of California San Diego -
University of California San Diego School of Medicine
Hospital
-
St. Joseph Hospital -
UC Irvine Medical Center
Drug Facts
| NPI NUMBER | 1144486929 | |
| NPPES Provider LastName | ESKANDER | |
| NPPES Provider FirstName | RAMEZ | |
| NPPES Provider ZIPCode | 921039001 | |
| NPPES Provider State | CA | |
| Specialty Description | Obstetrics/Gynecology | |
| Total Claim Count | 221.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 17.0 | |
| Percent Opioid Claims | 7.69 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1144486929 |
| Last Name Of The Provider | ESKANDER |
| First Name Of The Provider | RAMEZ |
| View All |
Similar Doctors
|
|
Dr. Randy P. Fiorentino, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mohammad M. Golshahi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Francisco A. Floriani, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alberto Manetta, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Yonatan Y. Mahller, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Josiah Hawkins, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daniel D. Dobalian, MD
This Doctor is OpenDoctor Recommended.
|